Lucas Bozzetti Pigozzi1, Duziene Denardini Pereira1, Marcos Pascoal Pattussi2, Carmen Moret-Tatay3,4, Tatiana Quarti Irigaray1, João Batista Blessmann Weber1, Patrícia Krieger Grossi5, Márcio Lima Grossi6. 1. School of Health and Life Sciences, Pontifical Catholic University of Rio Grande Do Sul (PUCRS), Avenida Ipiranga 6681 Prédio 6, Building 11, 9th Floor, Porto Alegre, RS, 90619-900, Brazil. 2. Public Health, Vale Do Rio Dos Sinos University (UNISINOS), Av. Unisinos, 950 - Cristo Rei, São Leopoldo, RS, 93020-190, Brazil. 3. Faculty of Psychology, Universidad Católica de Valencia San Vicente Mártir, Avenida de La Ilustración 4, 46100, Burjassot, Valencia, Spain. 4. Dipartimento Di Neuroscienze Salute Mentale E Organi Di Senso (NESMOS), Università Sapienza Di Roma, Rome, Italy. 5. School of Humanities, Pontifical Catholic University of Rio Grande Do Sul (PUCRS), Avenida Ipiranga 6681 Prédio 9, Porto Alegre, RS, 90619-900, Brazil. 6. School of Health and Life Sciences, Pontifical Catholic University of Rio Grande Do Sul (PUCRS), Avenida Ipiranga 6681 Prédio 6, Building 11, 9th Floor, Porto Alegre, RS, 90619-900, Brazil. mlgrossi@pucrs.br.
Abstract
AIMS: To compare the difference in the quality of life between temporomandibular disorders (TMD) patients and non-TMD subjects diagnosed with the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) or the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). METHODS: Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica database (EMBASE) and Latin American and Caribbean Health Sciences Literature (LILACS) databases were searched in studies published in English and Portuguese. The search was performed by two independent reviewers in duplicate. A manual search and the gray literature were also included. The inclusion criteria were clinical studies that used the RDC/TMD axis I and quality of life with standard questionnaires in young and middle-aged adult population (18-55 years). The data were analyzed quantitatively by combining the results in a meta-analysis using forest plots. The measure of effect used was the standardized mean difference (SMD) in depression levels. The Newcastle-Ottawa Scale (NOS) was used to evaluate the quality of the studies. The publication bias was assessed by funnel plots. The initial search included 806 articles without duplications. RESULTS: Twenty-four articles were included in the final systematic review. Of these, 9 were included in the meta-analysis, where it was shown a statistically significant in all axis I groups: (a) global TMD-groups I, II and III combined, N = 3829, SMD (95% CI) = 1.06 (0.65-1.51), p = 0.000; (b) group I-muscle disorders, N = 3,056, SMD (95% CI) = 0.82 (0.45-1.18), p = 0.000; (c) group II-disc displacements, N = 3,184, SMD (95% CI) = 0.59 (0.26-0.91), p = 0.000; and (d) group III-arthralgia/arthritis/arthrosis, N = 2781, SMD (95% CI) = 0.98 (0.59-1.36), p = 0.000. When compared to controls. CONCLUSIONS: Quality of life is affected in all axis I TMD patients, especially in groups I and III with higher pain intensity and disability as compared to group II.
AIMS: To compare the difference in the quality of life between temporomandibular disorders (TMD) patients and non-TMD subjects diagnosed with the Research Diagnostic Criteria for Temporomandibular Disorders (RDC/TMD) or the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD). METHODS: Medical Literature Analysis and Retrieval System Online (MEDLINE), Excerpta Medica database (EMBASE) and Latin American and Caribbean Health Sciences Literature (LILACS) databases were searched in studies published in English and Portuguese. The search was performed by two independent reviewers in duplicate. A manual search and the gray literature were also included. The inclusion criteria were clinical studies that used the RDC/TMD axis I and quality of life with standard questionnaires in young and middle-aged adult population (18-55 years). The data were analyzed quantitatively by combining the results in a meta-analysis using forest plots. The measure of effect used was the standardized mean difference (SMD) in depression levels. The Newcastle-Ottawa Scale (NOS) was used to evaluate the quality of the studies. The publication bias was assessed by funnel plots. The initial search included 806 articles without duplications. RESULTS: Twenty-four articles were included in the final systematic review. Of these, 9 were included in the meta-analysis, where it was shown a statistically significant in all axis I groups: (a) global TMD-groups I, II and III combined, N = 3829, SMD (95% CI) = 1.06 (0.65-1.51), p = 0.000; (b) group I-muscle disorders, N = 3,056, SMD (95% CI) = 0.82 (0.45-1.18), p = 0.000; (c) group II-disc displacements, N = 3,184, SMD (95% CI) = 0.59 (0.26-0.91), p = 0.000; and (d) group III-arthralgia/arthritis/arthrosis, N = 2781, SMD (95% CI) = 0.98 (0.59-1.36), p = 0.000. When compared to controls. CONCLUSIONS: Quality of life is affected in all axis I TMDpatients, especially in groups I and III with higher pain intensity and disability as compared to group II.
Authors: Mohammad A Moufti; Robert W Wassell; John G Meechan; Patrick F Allen; Mike T John; James G Steele Journal: Eur J Oral Sci Date: 2011-04 Impact factor: 2.612
Authors: Camila Maria Bastos Machado de Resende; Arthur César de Medeiros Alves; Lidiane Thomaz Coelho; Joõo Carlos Alchieri; Angelo Giuseppe Roncalli; Gustavo Augusto Seabra Barbosa Journal: Braz Oral Res Date: 2013-03-01
Authors: Geerten-Has E Tjakkes; Jan-Jaap Reinders; Elisabeth M Tenvergert; Boudewijn Stegenga Journal: Health Qual Life Outcomes Date: 2010-05-02 Impact factor: 3.186
Authors: Marco Antonio Silveira Santos; Alexia Guimarães Ramos; Thiago Carvalho de Sousa; Rodrigo Antonio de Medeiros Journal: Clin Oral Investig Date: 2022-10-11 Impact factor: 3.606
Authors: Mauro Henrique Nogueira Guimarães de Abreu; Alex Junio Silva Cruz; Ana Cristina Borges-Oliveira; Renata de Castro Martins; Flávio de Freitas Mattos Journal: Int J Environ Res Public Health Date: 2021-12-20 Impact factor: 3.390